Glioblastoma
RecruitingStudy on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients
- Disease:Glioblastoma
- Substances:Temozolomide
Norway- Participants:18–64 years · 65+ years
- Substances:Temozolomide
- Sponsor:Region Oestergoetland
Rare diseases
Investigational molecules
Locations
Back to Norway49 clinical trials in Graalum, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
Norway
NorwayThe busiest research cities in the country
What the registry says about research in the country
Research focusing on stroke prevention and innovative treatments for acute myocardial infarction. Clinical trials are evaluating new antiplatelet therapies and investigating novel approaches for stroke prevention in patients with atrial fibrillation.
Studies include evaluation of self-administered medications for heart attack symptoms and innovative anticoagulation strategies.
Groundbreaking studies in cancer treatment, with particular focus on pancreatic ductal cancer and advanced prostate cancer. Trials are exploring new therapeutic approaches and investigating the effectiveness of novel drug combinations.
Research includes prevention of cancer-related complications and innovative treatment strategies for metastatic disease.
Comprehensive research on respiratory infections and viral diseases, including studies on antibiotic therapy optimization and treatment of COVID-19. Clinical trials are evaluating novel therapeutic approaches for various infectious conditions.
Investigations include assessment of antiviral medications and optimization of treatment protocols.
Tell us about your condition – we search every trial in Europe and connect you with the right site.